| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |